Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients
NCT ID: NCT05715554
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2022-08-06
2023-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Homeopathy in Patients Suffering From Long COVID-19
NCT06002230
Evaluation of an Integrative Medicine Outpatient Clinical Setting for Post-COVID-19 Patients
NCT05630378
Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19
NCT06004362
The Homeogenomic Trial
NCT02018341
Effectiveness of Homeopathic Treatment in Female Infertility
NCT02175498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Homeopathy Group
Individualized Homeopathy Treatment provided by homeopathic physicians
Homeopathy
Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
Standard Group
Usual care provided by primary care physicians were followed by patients in the standard group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Homeopathy
Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Persistent respiratory symptoms for more than three months after COVID-19
* Able to provide informed consent
Exclusion Criteria
* On complementary and Alternative Treatment
* Symptoms of infection
* Pregnancy or Breastfeeding
* Cognitive impairment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gyansanjeevani India
UNKNOWN
Collaborative Homeopathy Research Network
UNKNOWN
Innowage Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sadhana Sharma
Role: PRINCIPAL_INVESTIGATOR
Gyansanjeevani India
Vesna Marinković
Role: STUDY_DIRECTOR
Collaborative Homeopathy Research Network
Neha Sharma
Role: STUDY_CHAIR
Innowage Limited
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gyansanjeevani India
Dausa, Rajasthan, India
Gyansanjeevani India
Jaipur, Rajasthan, India
Gyansanjeevani India
Mandāwa, Rajasthan, India
Gyansanjeevani India
Sawai Madhopur, Rajasthan, India
Gyansanjeevani India
Sīkar, Rajasthan, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I-G-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.